Kyle has had moderate to severe eczema across most of his body since he was an infant. Throughout his life, he’s faced a mix ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

The US FDA has approved Galderma's Nemluvio (nemolizumab), for individuals aged 12 years and above with moderate-to-severe atopic dermatitis.

Organon's VTAMA (tapinarof) cream is a first-in-class therapy with new FDA approval for atopic dermatitis in adults and children aged 2 and older.

Dermatology specialist Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to ...

Medically reviewed by Femi Aremu, PharmD Taking certain supplements in the winter can support overall health and combat the ...

In January, the British Association for Dermatologists warned about the growing trend of children using inappropriate ...

CHRISTMAS is a very busy time of the year for the NHS but it is also a pioneering anniversary when numerous life-saving ...

A woman's seemingly perfect relationship took a turn when cohabitation revealed her boyfriend's shocking hygiene habits. His ...

Novo Nordisk is investing more than $1 billion in a new production facility in Denmark. Elsewhere, drugs from Neurocrine ...